Corporate Governance

Chairman and director of several public and privately owned companies, primarily focusing on the medical device industry. Ron held various senior positions at Teva over the course of 20 years, including CEO Teva Israel and VP Israel & Africa.

Prior to joining IceCure, Eyal served as CEO of medical device and export companies, including B-Cure Laser and Hanita Lenses. Eyal is a seasoned executive and has extensive experience in global business development, particularly China and Japan.

Yankor has over 20 years of experience in the medical device industry in China, with companies such as Stryker and Johnson & Johnson.

Currently the VP of Business Operations & Site Lead for Medtronic PLC’s Caesarea site (formerly Mazor Robotics), Sharon is medical device veteran with extensive financial and business management experience in developing successful companies.

Entrepreneur, C-level Executive, Executive Chairman and Board member with over two decades of hands on top management experience spanning seed, growth and late stage public and private companies. Extensive track record of building and funding new ventures, establishing global business operations, growing revenues and bottom line, as well as turning around distressed companies and realizing shareholder value through M&A deals.

Mr. Chan has been a private equity executive for the past three decades, managing and leading more than 80 investment projects supporting company growth via funding and synergistic mergers and acquisitions. Since March 2021, he has been the Director of Samena Capital, a principal investment group, headquartered in Dubai, with three private equity funds and $390 million in assets under management, and was a Senior Managing Director and Head of Asia of Samena Capital Hong Kong Limited from 2016 to 2021.

Mr. Haixiang is the founder and managing partner of Virtus Inspire Ventures, a boutique venture capital firm that provides seed, venture and growth-stage funding to early-stage technology companies. Mr. Haixiang has been an independent non-executive director at AVO Insurance Company Holding since August 2018 and an independent non-executive director at FUTU Holding Limited (NASDAQ: FUTU) since March 2019. Mr. Haixiang has been a sole director at Chestnut Hill Ventures Limited since September 2015, a sole director at Virtus Inspire International Limited since August 2020, a sole director at Virtus Inspire Capital Limited since May 2012, a sole director at Virtus Inspire Ventures GP Limited since June 2015, a sole director at Virtus Inspire Ventures Management Limited since June 2015, a sole director at Sapientia Investment Consulting Limited since March 201, a sole director at the Kwan Limited since October 2021, a sole director at Virtus Inspire Aurora Limited since March 2021, a sole director at Virtus Inspire Partners Limited since March 2021, a sole director at Virtus Inspire SG Limited since October 2021, a sole director at VI Capital Pte Limited since June 2022, a sole director at VIPC 1 Limited since August 2022, a sole director at Virtus Inspire Holding Limited since February 2023, and a sole director at Virtus Inspire Group Limited since February 2023.

Mr. Haixiang received a BA from South China University of Technology and an MA from China Europe International Business School.